Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Leiomyosarcoma Uterus × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1107 Glioblastoma 431 Gliosarcoma 413 Osteosarcoma 307 Brain Neoplasms 279 Central Nervous System Neoplasms 249 Astrocytoma 230 Dendritic Cell Sarcoma, Interdigitating 222 Gastrointestinal Stromal Tumors 215 Glioma 197 Neoplasms 195 Lymphoma 194 Neuroblastoma 186 Rhabdomyosarcoma 179 Sarcoma, Ewing 176 Breast Neoplasms 175 Lymphoma, Non-Hodgkin 173 Burkitt Lymphoma 171 Recurrence 169 Oligodendroglioma 169 Precursor Cell Lymphoblastic Leukemia-Lymphoma 168 Lymphoma, Large B-Cell, Diffuse 150 Melanoma 149 Bone Neoplasms 145 Neoplasm Metastasis 144 Ovarian Neoplasms 143 Lymphoma, Follicular 135 Lymphoma, Mantle-Cell 123 Leukemia, Lymphocytic, Chronic, B-Cell 123 Hodgkin Disease 121

Interventions

Trabectedin 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06524583 2025-03-30

L-UteCIN

UNICANCER

Phase 2 Recruiting

Leiomyosarcoma Uterus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡